Some studies have confirmed the involvement of CARM1 in the pathogenesis of MM, and its selective inhibitors (e.g., EZM2302, TP064) have been shown to inhibit the tumor cell activity of MM [16, 17]. The gene discussed is CARM1; the disease is Miyoshi myopathy.